Serum Institute Of India’s New Rotavirus Vaccine Shows Nation’s Drug Development Potential

Devex: New Rotavirus vaccine shows India’s growing drug development promise
“A new vaccine against rotavirus made by the Serum Institute of India — the world’s largest vaccine manufacturer — and tested in Niger by Médecins Sans Frontières, is being hailed as a major public health breakthrough for children. … The [Serum Institute’s] development of Rotasil is also evidence of a growing drug development sector in India, a country previously known for remaking existing drugs in generic form. With its expertise in economical production, India’s drug industry could provide a significant boon to research on diseases that primarily affect the developing world…” (Cousins, 10/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.